Mole removal vs. standard care for vitiligo patients
Part of Cancer, Skin clinical trials.
This study compares removing the mole (halo nevus) versus leaving it alone in people who also have vitiligo. It aims to see if mole removal helps with skin repigmentation and disease control.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are between 6 and 45 years old
- You have a halo nevus (a mole with a white ring) plus non-segmental vitiligo
- Your vitiligo covers only a small area (less than 2% of your skin, not counting hands and feet)
- The mole is confirmed harmless by a skin exam
- You are healthy enough for minor surgery with local anesthesia
- You have no history of keloids (thick raised scars), autoimmune diseases, or recent use of hormone/light treatments
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests whether a special cell product (exosomes from umbilical cord stem cells) can safely help treat vitiligo. If you qualify, you might get this experimental treatment to see if it can restore skin color.
This Phase 2 trial tests whether a new drug called D-2570 can help restore skin color in people with non-segmental vitiligo (when white patches appear randomly across the body). The study will track how well the drug works and check if it's safe to use.
This study tests whether adding a short course of steroid pills (taken by mouth in a pulse pattern) to a skin-grafting procedure helps prevent a pale ring from forming around the treated spots in people with stable vitiligo. The procedure takes healthy, pigment-making skin cells from one area and applies them to the white patches.
This trial tests a new treatment for non-segmental vitiligo that uses a special liquid made from stem cells, applied through tiny needle pricks or small injections, alongside standard light therapy. It may help restore pigment to white patches with fewer side effects than traditional treatments.
This study tests a new medicine called FB102 for people with non-segmental vitiligo. It aims to see if the drug is safe and helps restore skin color.
This study tests a new way to treat vitiligo by combining a topical cream (methotrexate) with a special laser treatment (fractional CO2 laser) on similar patches on both sides of the body. It aims to see if this combination helps repigment the skin better.
Hear when a new Vitiligo trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.